Enzolytics Inc.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, NONOF has a market cap of 301.86B. Regarding current trading prices, ENZC is priced at $0.00, while NONOF trades at $68.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 19.32. In terms of profitability, ENZC's ROE is +0.00%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, ENZC is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CSLLY has a market cap of 151.00B. Regarding current trading prices, ENZC is priced at $0.00, while CSLLY trades at $77.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 28.66. In terms of profitability, ENZC's ROE is +0.00%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, ENZC is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CMXHF has a market cap of 73.10B. Regarding current trading prices, ENZC is priced at $0.00, while CMXHF trades at $150.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 27.70. In terms of profitability, ENZC's ROE is +0.00%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ENZC is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, UCBJY has a market cap of 34.92B. Regarding current trading prices, ENZC is priced at $0.00, while UCBJY trades at $91.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 29.93. In terms of profitability, ENZC's ROE is +0.00%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ENZC is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, ENZC is priced at $0.00, while ARGNF trades at $562.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, ENZC's ROE is +0.00%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, ENZC is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, UCBJF has a market cap of 33.40B. Regarding current trading prices, ENZC is priced at $0.00, while UCBJF trades at $175.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 28.67. In terms of profitability, ENZC's ROE is +0.00%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ENZC is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, ENZC is priced at $0.00, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ENZC's ROE is +0.00%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ENZC is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, GNMSF has a market cap of 12.81B. Regarding current trading prices, ENZC is priced at $0.00, while GNMSF trades at $208.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 12.23. In terms of profitability, ENZC's ROE is +0.00%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, ENZC is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, WXXWY has a market cap of 12.73B. Regarding current trading prices, ENZC is priced at $0.00, while WXXWY trades at $6.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 28.32. In terms of profitability, ENZC's ROE is +0.00%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ENZC is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, ENZC is priced at $0.00, while WXIBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, ENZC's ROE is +0.00%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ENZC is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, IVBXF has a market cap of 11.67B. Regarding current trading prices, ENZC is priced at $0.00, while IVBXF trades at $7.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is -707.54. In terms of profitability, ENZC's ROE is +0.00%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ENZC is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, ENZC is priced at $0.00, while SBMFF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, ENZC's ROE is +0.00%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ENZC is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, ENZC is priced at $0.00, while SBHMY trades at $9.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, ENZC's ROE is +0.00%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ENZC is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, TRSBF has a market cap of 6.49B. Regarding current trading prices, ENZC is priced at $0.00, while TRSBF trades at $2.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 30.56. In terms of profitability, ENZC's ROE is +0.00%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ENZC is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, TLPPF has a market cap of 5.55B. Regarding current trading prices, ENZC is priced at $0.00, while TLPPF trades at $16.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is 182.44. In terms of profitability, ENZC's ROE is +0.00%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ENZC is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, ENZC is priced at $0.00, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ENZC's ROE is +0.00%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ENZC is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, ENZC is priced at $0.00, while INCPF trades at $3.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ENZC's ROE is +0.00%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ENZC is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, ENZC is priced at $0.00, while AKBLF trades at $21.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, ENZC's ROE is +0.00%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, ENZC is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, ENZC is priced at $0.00, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ENZC's ROE is +0.00%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ENZC is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ZLDPF has a market cap of 4.48B. Regarding current trading prices, ENZC is priced at $0.00, while ZLDPF trades at $63.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is -24.49. In terms of profitability, ENZC's ROE is +0.00%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, ENZC is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SHJBF has a market cap of 3.50B. Regarding current trading prices, ENZC is priced at $0.00, while SHJBF trades at $1.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, ENZC's ROE is +0.00%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ENZC is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CAMRF has a market cap of 3.28B. Regarding current trading prices, ENZC is priced at $0.00, while CAMRF trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 59.57. In terms of profitability, ENZC's ROE is +0.00%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ENZC is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, REGMF has a market cap of 3.27B. Regarding current trading prices, ENZC is priced at $0.00, while REGMF trades at $5.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ENZC's ROE is +0.00%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ENZC is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, ENZC is priced at $0.00, while GNNSF trades at $1.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, ENZC's ROE is +0.00%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ENZC is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, ENZC is priced at $0.00, while TKBIF trades at $23.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ENZC's ROE is +0.00%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ENZC is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, ENZC is priced at $0.00, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ENZC's ROE is +0.00%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, ENZC is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, ENZC is priced at $0.00, while ASPHF trades at $6.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ENZC's ROE is +0.00%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ENZC is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, ENZC is priced at $0.00, while BVNKF trades at $26.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 10.63. In terms of profitability, ENZC's ROE is +0.00%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, ENZC is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BVNRY has a market cap of 2.01B. Regarding current trading prices, ENZC is priced at $0.00, while BVNRY trades at $8.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 10.27. In terms of profitability, ENZC's ROE is +0.00%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, ENZC is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, ENZC is priced at $0.00, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, ENZC's ROE is +0.00%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ENZC is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, GENSF has a market cap of 1.83B. Regarding current trading prices, ENZC is priced at $0.00, while GENSF trades at $27.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is -348.31. In terms of profitability, ENZC's ROE is +0.00%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ENZC is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, ENZC is priced at $0.00, while MEOBF trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, ENZC's ROE is +0.00%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ENZC is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, GLPGF has a market cap of 1.81B. Regarding current trading prices, ENZC is priced at $0.00, while GLPGF trades at $27.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -9.02. In terms of profitability, ENZC's ROE is +0.00%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ENZC is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, ENZC is priced at $0.00, while PPTDF trades at $13.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is 17.35. In terms of profitability, ENZC's ROE is +0.00%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ENZC is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BRCTF has a market cap of 1.68B. Regarding current trading prices, ENZC is priced at $0.00, while BRCTF trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is -90.40. In terms of profitability, ENZC's ROE is +0.00%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ENZC is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BIESF has a market cap of 1.62B. Regarding current trading prices, ENZC is priced at $0.00, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -45.71. In terms of profitability, ENZC's ROE is +0.00%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ENZC is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ONTTF has a market cap of 1.54B. Regarding current trading prices, ENZC is priced at $0.00, while ONTTF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -7.62. In terms of profitability, ENZC's ROE is +0.00%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ENZC is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, ENZC is priced at $0.00, while PHMMF trades at $80.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 64.21. In terms of profitability, ENZC's ROE is +0.00%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ENZC is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, ENZC is priced at $0.00, while CSBTF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, ENZC's ROE is +0.00%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ENZC is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, ENZC is priced at $0.00, while NURPF trades at $8.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 11.63. In terms of profitability, ENZC's ROE is +0.00%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ENZC is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ASCLF has a market cap of 865.80M. Regarding current trading prices, ENZC is priced at $0.00, while ASCLF trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -22.33. In terms of profitability, ENZC's ROE is +0.00%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ENZC is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, ENZC is priced at $0.00, while CSPHF trades at $0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, ENZC's ROE is +0.00%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ENZC is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PHGUF has a market cap of 680.31M. Regarding current trading prices, ENZC is priced at $0.00, while PHGUF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, ENZC's ROE is +0.00%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, ENZC is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, ENZC is priced at $0.00, while BPMUF trades at $47.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 6.85. In terms of profitability, ENZC's ROE is +0.00%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ENZC is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, ENZC is priced at $0.00, while INRLF trades at $3.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -5.16. In terms of profitability, ENZC's ROE is +0.00%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, ENZC is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SOLTF has a market cap of 534.16M. Regarding current trading prices, ENZC is priced at $0.00, while SOLTF trades at $5.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, ENZC's ROE is +0.00%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ENZC is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BXPHF has a market cap of 517.79M. Regarding current trading prices, ENZC is priced at $0.00, while BXPHF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BXPHF's P/E ratio is -26.50. In terms of profitability, ENZC's ROE is +0.00%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ENZC is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, ENZC is priced at $0.00, while IVEVF trades at $3.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ENZC's ROE is +0.00%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ENZC is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, ENZC is priced at $0.00, while CLTEF trades at $7.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ENZC's ROE is +0.00%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, ENZC is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, ENZC is priced at $0.00, while SNBIF trades at $6.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ENZC's ROE is +0.00%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ENZC is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, ENZC is priced at $0.00, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ENZC's ROE is +0.00%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ENZC is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, ENZC is priced at $0.00, while AAVXF trades at $7.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, ENZC's ROE is +0.00%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, ENZC is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, VBIZF has a market cap of 456.09M. Regarding current trading prices, ENZC is priced at $0.00, while VBIZF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 21.89. In terms of profitability, ENZC's ROE is +0.00%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ENZC is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, ENZC is priced at $0.00, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ENZC's ROE is +0.00%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ENZC is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CYDY has a market cap of 418.90M. Regarding current trading prices, ENZC is priced at $0.00, while CYDY trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -16.99. In terms of profitability, ENZC's ROE is +0.00%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ENZC is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, ENZC is priced at $0.00, while HBMHF trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, ENZC's ROE is +0.00%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ENZC is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, ENZC is priced at $0.00, while PTCHF trades at $1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, ENZC's ROE is +0.00%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ENZC is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, NWBO has a market cap of 390.68M. Regarding current trading prices, ENZC is priced at $0.00, while NWBO trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -3.87. In terms of profitability, ENZC's ROE is +0.00%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, ENZC is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, IDRSF has a market cap of 377.58M. Regarding current trading prices, ENZC is priced at $0.00, while IDRSF trades at $1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -1.04. In terms of profitability, ENZC's ROE is +0.00%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, ENZC is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, ENZC is priced at $0.00, while CLVLF trades at $6.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, ENZC's ROE is +0.00%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ENZC is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CLVLY has a market cap of 336.83M. Regarding current trading prices, ENZC is priced at $0.00, while CLVLY trades at $6.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 13.71. In terms of profitability, ENZC's ROE is +0.00%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ENZC is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, NGENF has a market cap of 333.93M. Regarding current trading prices, ENZC is priced at $0.00, while NGENF trades at $4.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -17.20. In terms of profitability, ENZC's ROE is +0.00%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ENZC is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, ENZC is priced at $0.00, while PRRUF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, ENZC's ROE is +0.00%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ENZC is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, ENZC is priced at $0.00, while BOVNF trades at $4.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, ENZC's ROE is +0.00%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ENZC is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, ENZC is priced at $0.00, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ENZC's ROE is +0.00%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ENZC is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, ENZC is priced at $0.00, while ORYZF trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ENZC's ROE is +0.00%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ENZC is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, ENZC is priced at $0.00, while NWPHF trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ENZC's ROE is +0.00%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ENZC is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, ENZC is priced at $0.00, while MDCLF trades at $6.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, ENZC's ROE is +0.00%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ENZC is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, ENZC is priced at $0.00, while HLOSF trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -7.26. In terms of profitability, ENZC's ROE is +0.00%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ENZC is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, ENZC is priced at $0.00, while SPHDF trades at $17.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -3.99. In terms of profitability, ENZC's ROE is +0.00%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ENZC is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, ENZC is priced at $0.00, while RAONF trades at $1.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -20.33. In terms of profitability, ENZC's ROE is +0.00%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ENZC is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, ENZC is priced at $0.00, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ENZC's ROE is +0.00%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ENZC is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, ENZC is priced at $0.00, while VSBC trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas VSBC's P/E ratio is N/A. In terms of profitability, ENZC's ROE is +0.00%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ENZC is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, ENZC is priced at $0.00, while FGHQF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ENZC's ROE is +0.00%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ENZC is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, ENZC is priced at $0.00, while HNSBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, ENZC's ROE is +0.00%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ENZC is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BSEM has a market cap of 194.88M. Regarding current trading prices, ENZC is priced at $0.00, while BSEM trades at $11.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BSEM's P/E ratio is -20.93. In terms of profitability, ENZC's ROE is +0.00%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ENZC is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, ENZC is priced at $0.00, while GNFTF trades at $3.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, ENZC's ROE is +0.00%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ENZC is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, ENZC is priced at $0.00, while SCNLF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, ENZC's ROE is +0.00%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ENZC is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, ENZC is priced at $0.00, while OPORF trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas OPORF's P/E ratio is 12.00. In terms of profitability, ENZC's ROE is +0.00%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ENZC is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, ENZC is priced at $0.00, while MLLCF trades at $4.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -2.09. In terms of profitability, ENZC's ROE is +0.00%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ENZC is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, AVCTF has a market cap of 153.80M. Regarding current trading prices, ENZC is priced at $0.00, while AVCTF trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, ENZC's ROE is +0.00%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ENZC is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, ENZC is priced at $0.00, while RECEF trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -10.00. In terms of profitability, ENZC's ROE is +0.00%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ENZC is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, SLNCF has a market cap of 137.44M. Regarding current trading prices, ENZC is priced at $0.00, while SLNCF trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -1.90. In terms of profitability, ENZC's ROE is +0.00%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, ENZC is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, ENZC is priced at $0.00, while BRIBF trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, ENZC's ROE is +0.00%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ENZC is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, ENZC is priced at $0.00, while IPHYF trades at $1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.13. In terms of profitability, ENZC's ROE is +0.00%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, ENZC is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, ENZC is priced at $0.00, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ENZC's ROE is +0.00%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ENZC is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, ENZC is priced at $0.00, while PRNAF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, ENZC's ROE is +0.00%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, ENZC is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, ENZC is priced at $0.00, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ENZC's ROE is +0.00%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ENZC is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, ENZC is priced at $0.00, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ENZC's ROE is +0.00%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ENZC is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, ENZC is priced at $0.00, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ENZC's ROE is +0.00%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, ENZC is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, ENZC is priced at $0.00, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ENZC's ROE is +0.00%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ENZC is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, ENZC is priced at $0.00, while PBIGF trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, ENZC's ROE is +0.00%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ENZC is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, ENZC is priced at $0.00, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ENZC's ROE is +0.00%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, ENZC is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, IUGNF has a market cap of 97.07M. Regarding current trading prices, ENZC is priced at $0.00, while IUGNF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas IUGNF's P/E ratio is -1.30. In terms of profitability, ENZC's ROE is +0.00%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ENZC is more volatile compared to IUGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, ENZC is priced at $0.00, while TRGNF trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.19. In terms of profitability, ENZC's ROE is +0.00%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ENZC is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, ENZC is priced at $0.00, while CMVLF trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, ENZC's ROE is +0.00%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ENZC is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, ENZC is priced at $0.00, while MCURF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ENZC's ROE is +0.00%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ENZC is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, ACHFF has a market cap of 80.74M. Regarding current trading prices, ENZC is priced at $0.00, while ACHFF trades at $1.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas ACHFF's P/E ratio is -30.62. In terms of profitability, ENZC's ROE is +0.00%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, ENZC is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.

ENZC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ENZC stands at 2.76M. In comparison, MSCLF has a market cap of 77.95M. Regarding current trading prices, ENZC is priced at $0.00, while MSCLF trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ENZC currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 2.61. In terms of profitability, ENZC's ROE is +0.00%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, ENZC is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZC.